| 1 | Peritoneal Neoplasms | 43.1% |
| 2 | Gastrointestinal Neoplasms | 38.3% |
| 3 | Liver neoplasms | 38.3% |
| 4 | Parathyroid Neoplasms | 36.9% |
| 5 | Thyroid Neoplasm | 36.9% |
| 6 | Thyroid carcinoma | 36.9% |
| 7 | Esophageal Neoplasms | 34.6% |
| 8 | Adrenal Gland Neoplasms | 31.3% |
| 9 | Multiple Endocrine Neoplasia | 30.6% |
| 10 | Bile Duct Neoplasms | 29.4% |
| 11 | gallbladder neoplasm | 29.4% |
| 12 | Intestinal Neoplasms | 29.4% |
| 13 | Stomach Neoplasms | 29.4% |
| 14 | Testicular Neoplasms | 27.2% |
| 15 | Thyroid Nodule | 27.1% |
| 16 | Hepatocellular Adenoma | 27.1% |
| 17 | Liver Neoplasms, Experimental | 26.5% |
| 18 | Colorectal Neoplasms | 25.7% |
| 19 | Cecal Neoplasms | 25% |
| 20 | Duodenal Neoplasms | 25% |
| 21 | Zollinger-Ellison syndrome | 24.4% |
| 22 | ovarian neoplasm | 23.8% |
| 23 | Adenomatous Polyposis Coli | 22.4% |
| 24 | Appendiceal Neoplasms | 22.4% |
| 25 | Colonic Neoplasms | 22.4% |
| 26 | Rectal Neoplasms | 22.4% |
| 27 | Pancreatic Cyst | 22% |
| 28 | Pituitary Adenoma | 21.8% |
| 29 | Pituitary Neoplasms | 21.8% |
| 30 | Anus Neoplasms | 21.8% |
| 31 | Sigmoid Neoplasms | 21.8% |
| 32 | Multiple Endocrine Neoplasia Type 1 | 21.6% |
| 33 | Abdominal Neoplasms | 20.9% |
| 34 | Head and Neck Neoplasms | 20.9% |
| 35 | Soft Tissue Neoplasms | 20.9% |
| 36 | Thoracic Neoplasms | 20.9% |
| 37 | Pancreatic Fistula | 20.8% |
| 38 | Prolactinoma | 20.2% |
| 39 | Growth Hormone-Secreting Pituitary Adenoma | 20.2% |
| 40 | Pancreatic Insufficiency | 18.6% |
| 41 | Pancreatitis | 18.6% |
| 42 | Eye Neoplasms | 18.4% |
| 43 | Nervous System Neoplasms | 18.4% |
| 44 | Adrenocortical carcinoma | 18.3% |
| 45 | Bone neoplasms | 18% |
| 46 | Skin Neoplasms | 18% |
| 47 | Hematologic Neoplasms | 18% |
| 48 | Gastrointestinal Stromal Tumors | 17.9% |
| 49 | granulosa cell tumor | 17.9% |
| 50 | Carcinoma, Ovarian Epithelial | 17.9% |
| 51 | Splenic Neoplasms | 17.8% |
| 52 | Leydig Cell Tumor | 17.3% |
| 53 | Nelson Syndrome | 16.7% |
| 54 | Tracheal Neoplasms | 16.1% |
| 55 | Pancreatic Pseudocyst | 15.7% |
| 56 | Paraneoplastic Encephalomyelitis | 15.7% |
| 57 | Proctocolitis | 15.6% |
| 58 | Mammary Neoplasms, Experimental | 15.5% |
| 59 | Choledochal Cyst | 15.4% |
| 60 | Digestive System Neoplasms | 15.3% |
| 61 | Acanthoma | 14.6% |
| 62 | Biliary Tract Diseases | 14.3% |
| 63 | Gastrointestinal Diseases | 14.3% |
| 64 | Liver diseases | 14.3% |
| 65 | Biliary cirrhosis | 14% |
| 66 | Pancreatic Neoplasm | 13.9% |
| 67 | Retroperitoneal Neoplasms | 13.8% |
| 68 | Pancreatitis, Chronic | 13.8% |
| 69 | Carcinoma, Lobular | 13.1% |
| 70 | Duodenitis | 12.7% |
| 71 | Ileitis | 12.7% |
| 72 | Erosive Duodenitis | 12.7% |
| 73 | Cystic Fibrosis | 12.5% |
| 74 | Congenital Hyperinsulinism | 12.2% |
| 75 | Mesenteric vascular insufficiency | 12.2% |
| 76 | Esophageal Atresia | 12.1% |
| 77 | Intestinal Atresia | 12.1% |
| 78 | Mesenteric Vascular Occlusion | 12.1% |
| 79 | Intestinal Fistula | 12% |
| 80 | Enterocutaneous Fistula | 12% |
| 81 | Rectal Fistula | 12% |
| 82 | Anal Fistula | 12% |
| 83 | Hamartoma | 11.9% |
| 84 | Neoplasms, Hormone-Dependent | 11.9% |
| 85 | Neoplasms, Multiple Primary | 11.9% |
| 86 | Paraneoplastic Syndromes | 11.9% |
| 87 | Precancerous Conditions | 11.9% |
| 88 | Neoplasms, Second Primary | 11.9% |
| 89 | Barrett Esophagus | 11.9% |
| 90 | Mouth Neoplasms | 11.9% |
| 91 | Central Nervous System Neoplasms | 11.9% |
| 92 | Vascular Neoplasms | 11.9% |
| 93 | Thymus Neoplasms | 11.9% |
| 94 | Dysentery | 11.8% |
| 95 | Enteritis | 11.8% |
| 96 | Enterocolitis | 11.8% |
| 97 | Esophageal and Gastric Varices | 11.8% |
| 98 | Esophagitis | 11.8% |
| 99 | Gastritis | 11.8% |
| 100 | Genital Neoplasms, Female | 11.8% |
| 101 | Inflammatory Bowel Diseases | 11.8% |
| 102 | Cholecystolithiasis | 11.8% |
| 103 | Breast Neoplasms, Male | 11.7% |
| 104 | Pancreatitis, Alcoholic | 11.7% |
| 105 | Triple Negative Breast Neoplasms | 11.7% |
| 106 | Meningioma | 11.6% |
| 107 | Pouchitis | 11.3% |
| 108 | Thymoma | 11.1% |
| 109 | Acoustic Neuroma | 11.1% |
| 110 | Carcinoma, Pancreatic Ductal | 11% |
| 111 | Colitis | 10.7% |
| 112 | Duodenogastric Reflux | 10.7% |
| 113 | Peptic Ulcer | 10.7% |
| 114 | Proctitis | 10.7% |
| 115 | Choledocholithiasis | 10.7% |
| 116 | Genital Neoplasms, Male | 10.4% |
| 117 | Uveal Neoplasms | 10.4% |
| 118 | Urologic Neoplasms | 10.3% |
| 119 | Nose Neoplasms | 10.3% |
| 120 | Sebaceous Gland Neoplasms | 10.3% |
| 121 | Spinal Neoplasms | 10.3% |
| 122 | Bone Marrow Neoplasms | 10.3% |
| 123 | Cyst | 10.2% |
| 124 | Neoplastic Processes | 10.2% |
| 125 | Neoplastic Syndromes, Hereditary | 10.2% |
| 126 | Pregnancy Complications, Neoplastic | 10.2% |
| 127 | Fatty Liver, Alcoholic | 10.2% |
| 128 | Hepatitis, Alcoholic | 10.2% |
| 129 | Liver Cirrhosis, Alcoholic | 10.2% |
| 130 | Neoplasms, Experimental | 10.1% |
| 131 | Palatal Neoplasms | 10.1% |
| 132 | Leukoplakia, Oral | 9.8% |
| 133 | Carcinoma 256, Walker | 9.8% |
| 134 | Paraneoplastic Cerebellar Degeneration | 9.8% |
| 135 | Crohn Disease | 9.7% |
| 136 | Duodenal Obstruction | 9.7% |
| 137 | Enterocolitis, Neutropenic | 9.7% |
| 138 | Necrotizing Enterocolitis | 9.7% |
| 139 | Retinoblastoma | 9.5% |
| 140 | Appendicitis | 9.4% |
| 141 | Vipoma | 9.4% |
| 142 | Optic Nerve Glioma | 9.3% |
| 143 | Bile Duct Diseases | 9.3% |
| 144 | Cholelithiasis | 9.3% |
| 145 | Chylous Ascites | 9.3% |
| 146 | Esophageal Diseases | 9.3% |
| 147 | Fatty Liver | 9.3% |
| 148 | Gastroenteritis | 9.3% |
| 149 | Hepatitis | 9.3% |
| 150 | Portal Hypertension | 9.3% |
| 151 | Intestinal Diseases | 9.3% |
| 152 | Liver Cirrhosis | 9.3% |
| 153 | Pneumoperitoneum | 9.3% |
| 154 | Stomach Diseases | 9.3% |
| 155 | Focal Nodular Hyperplasia | 9.3% |
| 156 | Hepatic Insufficiency | 9.3% |
| 157 | Steatohepatitis | 9.3% |
| 158 | Duodenal Ulcer | 9.2% |
| 159 | Peptic Ulcer Perforation | 9.2% |
| 160 | Gastric ulcer | 9.2% |
| 161 | Endocrine Gland Neoplasms | 9.2% |
| 162 | Melanoma, Experimental | 9.1% |
| 163 | insulinoma | 9% |
| 164 | Nephroblastoma | 9% |
| 165 | Nesidioblastosis | 9% |
| 166 | Gastrinoma | 8.9% |
| 167 | Glucagonoma | 8.9% |
| 168 | Carcinoma, Ehrlich Tumor | 8.9% |
| 169 | Dermoid Cyst | 8.9% |
| 170 | Carcinoma, Lewis Lung | 8.9% |
| 171 | Tuberous Sclerosis | 8.8% |
| 172 | Neoplasms, Radiation-Induced | 8.8% |
| 173 | Meningeal Neoplasms | 8.8% |
| 174 | Limbic Encephalitis | 8.8% |
| 175 | Trophoblastic Neoplasms | 8.6% |
| 176 | Leukemia, Experimental | 8.6% |
| 177 | Neoplasms, Neuroepithelial | 8.5% |
| 178 | Gliomatosis cerebri | 8.5% |
| 179 | Colonic Pseudo-Obstruction | 8.4% |
| 180 | Enterocolitis, Pseudomembranous | 8.4% |
| 181 | pseudomembranous colitis | 8.4% |
| 182 | Dysentery, Bacillary | 8.4% |
| 183 | Medulloblastoma | 8.4% |
| 184 | Peutz-Jeghers Syndrome | 8.3% |
| 185 | Liver Abscess, Amebic | 8.2% |
| 186 | Liver Diseases, Parasitic | 8.2% |
| 187 | Colitis, Ischemic | 8.1% |
| 188 | Lambert-Eaton Myasthenic Syndrome | 8% |
| 189 | Hepatic Veno-Occlusive Disease | 8% |
| 190 | Peliosis Hepatis | 8% |
| 191 | Hepatopulmonary Syndrome | 8% |
| 192 | Anus, Imperforate | 7.9% |
| 193 | Gastrointestinal Hemorrhage | 7.9% |
| 194 | Hemoperitoneum | 7.9% |
| 195 | Hepatomegaly | 7.9% |
| 196 | Mesenteric Panniculitis | 7.9% |
| 197 | Panniculitis, Peritoneal | 7.9% |
| 198 | Peritonitis | 7.9% |
| 199 | Peritoneal Fibrosis | 7.9% |
| 200 | Encapsulating Peritoneal Sclerosis | 7.9% |
| 201 | Anorectal Malformations | 7.9% |
| 202 | Biliary Fistula | 7.9% |
| 203 | Gastric Fistula | 7.9% |
| 204 | Hepatic Vein Thrombosis | 7.9% |
| 205 | Liver Abscess | 7.9% |
| 206 | Budd-Chiari Syndrome | 7.9% |
| 207 | Tuberculosis, Gastrointestinal | 7.9% |
| 208 | Neuroectodermal Tumors | 7.8% |
| 209 | Ear Neoplasms | 7.8% |
| 210 | Eyelid Neoplasms | 7.8% |
| 211 | Lung Neoplasms | 7.8% |
| 212 | Pleural Neoplasms | 7.8% |
| 213 | Corpus Luteum Cyst | 7.7% |
| 214 | Ovarian Cysts | 7.7% |
| 215 | Sarcoma, Experimental | 7.7% |
| 216 | Leukemia, Radiation-Induced | 7.7% |
| 217 | Brain Neoplasms | 7.7% |
| 218 | Salivary Gland Neoplasms | 7.7% |
| 219 | Spinal Cord Neoplasms | 7.7% |
| 220 | Tongue Neoplasms | 7.7% |
| 221 | melanoma | 7.6% |
| 222 | Uterine Neoplasms | 7.6% |
| 223 | Vaginal Neoplasms | 7.6% |
| 224 | Vulvar Neoplasms | 7.6% |
| 225 | Uterine Cancer | 7.6% |
| 226 | Fallopian Tube Neoplasms | 7.6% |
| 227 | Opsoclonus-Myoclonus Syndrome | 7.3% |
| 228 | Meningeal Carcinomatosis | 7.3% |
| 229 | Adrenal Gland Diseases | 7.1% |
| 230 | Gonadal Disorders | 7.1% |
| 231 | Pancreatic Diseases | 7.1% |
| 232 | Parathyroid Diseases | 7.1% |
| 233 | Thyroid Diseases | 7.1% |
| 234 | Choriocarcinoma | 7.1% |
| 235 | Hepatitis B, Chronic | 7.1% |
| 236 | Hepatitis C, Chronic | 7.1% |
| 237 | Carcinoma, Endometrioid | 7.1% |
| 238 | Chemical and Drug Induced Liver Injury | 7% |
| 239 | Erythroplasia | 7% |
| 240 | Follicular cyst | 7% |
| 241 | leukemia | 7% |
| 242 | Mucocele | 7% |
| 243 | Neoplasms, Germ Cell and Embryonal | 7% |
| 244 | Neoplasms, Glandular and Epithelial | 7% |
| 245 | Pilonidal Cyst | 7% |
| 246 | Thyroglossal Cyst | 7% |
| 247 | Synovial Cyst | 7% |
| 248 | Germ Cell Cancer | 7% |
| 249 | Aberrant Crypt Foci | 7% |
| 250 | Mesoblastic Nephroma | 7% |
| 251 | Pharyngeal Neoplasms | 6.9% |
| 252 | Cecal Diseases | 6.9% |
| 253 | Cholangitis | 6.9% |
| 254 | Cholecystitis | 6.9% |
| 255 | Cholestasis | 6.9% |
| 256 | Colonic Diseases | 6.9% |
| 257 | Common Bile Duct Diseases | 6.9% |
| 258 | Esophageal Stenosis | 6.9% |
| 259 | Hepatitis, Chronic | 6.9% |
| 260 | Ileal Diseases | 6.9% |
| 261 | Intestinal Obstruction | 6.9% |
| 262 | Intestinal Perforation | 6.9% |
| 263 | Jejunal Diseases | 6.9% |
| 264 | Pneumatosis Cystoides Intestinalis | 6.9% |
| 265 | Rectal Diseases | 6.9% |
| 266 | Gastric Dilatation | 6.9% |
| 267 | Liver Failure | 6.9% |
| 268 | Gastric outlet obstruction | 6.9% |
| 269 | Cronkhite-Canada Syndrome | 6.9% |
| 270 | Non-alcoholic Fatty Liver Disease | 6.9% |
| 271 | Chronic active hepatitis | 6.9% |
| 272 | Intestinal Polyposis | 6.9% |
| 273 | Hepatorenal Syndrome | 6.9% |
| 274 | Central Nervous System Cysts | 6.8% |
| 275 | Carcinosarcoma | 6.8% |
| 276 | Hemangiosarcoma | 6.8% |
| 277 | Leukemia L1210 | 6.8% |
| 278 | Leukemia P388 | 6.8% |
| 279 | lymphangiosarcoma | 6.8% |
| 280 | Penile Neoplasms | 6.8% |
| 281 | Prostatic Neoplasms | 6.8% |
| 282 | Adenoma, Acidophil | 6.7% |
| 283 | Ganglioneuroma | 6.7% |
| 284 | Glioma | 6.7% |
| 285 | Malignant Glioma | 6.7% |
| 286 | Polycythemia Vera | 6.7% |
| 287 | Myelitis, Transverse | 6.7% |
| 288 | Basal Cell Nevus Syndrome | 6.5% |
| 289 | Bronchial Neoplasms | 6.4% |
| 290 | Multiple Pulmonary Nodules | 6.4% |
| 291 | Lymphomatoid Granulomatosis | 6.4% |
| 292 | Sarcoma 180 | 6.3% |
| 293 | Supratentorial Neoplasms | 6.3% |
| 294 | Carcinoid Tumor | 6.3% |
| 295 | Endometrial Neoplasms | 6.3% |
| 296 | Neurilemmoma | 6.3% |
| 297 | Hutchinson's Melanotic Freckle | 6.3% |
| 298 | Melanoma, Amelanotic | 6.3% |
| 299 | Laryngeal neoplasm | 6.3% |
| 300 | Denys-Drash Syndrome | 6.3% |
| 301 | Bone Diseases, Endocrine | 6.1% |
| 302 | Porphyrias, Hepatic | 6.1% |
| 303 | Bladder Neoplasm | 6.1% |
| 304 | Diabetes Mellitus | 6.1% |
| 305 | Esophageal Perforation | 6.1% |
| 306 | Hepatitis, Animal | 6.1% |
| 307 | Hepatitis, Viral, Human | 6.1% |
| 308 | Intestinal Diseases, Parasitic | 6.1% |
| 309 | Kidney Neoplasm | 6.1% |
| 310 | Ureteral Neoplasms | 6.1% |
| 311 | Urethral Neoplasms | 6.1% |
| 312 | Pituitary Diseases | 6% |
| 313 | Renal Cell Carcinoma | 6% |
| 314 | Papillary Renal Cell Carcinoma | 6% |
| 315 | Composite Lymphoma | 6% |
| 316 | Leukoplakia | 6% |
| 317 | Lymphocele | 6% |
| 318 | Breast Cyst | 5.9% |
| 319 | Deglutition Disorders | 5.9% |
| 320 | Histiocytic Disorders, Malignant | 5.9% |
| 321 | Actinic keratosis | 5.9% |
| 322 | Mediastinal Cyst | 5.9% |
| 323 | Neoplasm Invasiveness | 5.9% |
| 324 | Neoplasm Metastasis | 5.9% |
| 325 | Neoplasm Recurrence, Local | 5.9% |
| 326 | Parovarian Cyst | 5.9% |
| 327 | Pericardial Cyst | 5.9% |
| 328 | Thymic Cyst | 5.9% |
| 329 | Carcinogenesis | 5.9% |
| 330 | Myxoid cyst | 5.9% |
| 331 | Metastasis | 5.9% |
| 332 | Leukemia, Plasma Cell | 5.9% |
| 333 | Achlorhydria | 5.9% |
| 334 | Liver Cirrhosis, Experimental | 5.9% |
| 335 | Gastric Antral Vascular Ectasia | 5.9% |
| 336 | Astrocytoma | 5.9% |
| 337 | Ependymoma | 5.9% |
| 338 | oligodendroglioma | 5.9% |
| 339 | Ganglioglioma | 5.9% |
| 340 | gliosarcoma | 5.9% |
| 341 | Anaplastic astrocytoma | 5.9% |
| 342 | Anaplastic Oligodendroglioma | 5.9% |
| 343 | Peptic Ulcer Hemorrhage | 5.9% |
| 344 | Gastroparesis | 5.9% |
| 345 | Basal cell carcinoma | 5.8% |
| 346 | Carcinoma, Papillary | 5.8% |
| 347 | Squamous cell carcinoma | 5.8% |
| 348 | Chondrosarcoma | 5.8% |
| 349 | Craniopharyngioma | 5.8% |
| 350 | Cystadenoma | 5.8% |
| 351 | leiomyosarcoma | 5.8% |
| 352 | liposarcoma | 5.8% |
| 353 | Mesothelioma | 5.8% |
| 354 | synovial sarcoma | 5.8% |
| 355 | Neuroectodermal Tumor, Melanotic | 5.8% |
| 356 | Angiomyolipoma | 5.8% |
| 357 | Clear Cell Sarcoma of Soft Tissue | 5.8% |
| 358 | Alveolar Soft Part Sarcoma | 5.8% |
| 359 | Neuroendocrine Tumors | 5.8% |
| 360 | Sarcoma, Myeloid | 5.8% |
| 361 | Carcinoma, Basal Cell | 5.8% |
| 362 | Cholestasis, Extrahepatic | 5.7% |
| 363 | Biliary Dyskinesia | 5.7% |
| 364 | Cholangitis, Sclerosing | 5.7% |
| 365 | Colonic Diseases, Functional | 5.7% |
| 366 | Esophageal motility disorders | 5.7% |
| 367 | Fecal Incontinence | 5.7% |
| 368 | Fecal Impaction | 5.7% |
| 369 | Intussusception | 5.7% |
| 370 | Mallory-Weiss Syndrome | 5.7% |
| 371 | Megacolon | 5.7% |
| 372 | Pyloric Stenosis | 5.7% |
| 373 | Liver Failure, Acute | 5.7% |
| 374 | Acalculous Cholecystitis | 5.7% |
| 375 | End Stage Liver Disease | 5.7% |
| 376 | Ileus | 5.7% |
| 377 | Meconium ileus | 5.7% |
| 378 | Brain Stem Neoplasms | 5.7% |
| 379 | Hypopharyngeal Neoplasms | 5.6% |
| 380 | Pleural Effusion, Malignant | 5.6% |
| 381 | Hypopharyngeal Cancer | 5.6% |
| 382 | Malignant Carcinoid Syndrome | 5.6% |
| 383 | Parotid Neoplasms | 5.6% |
| 384 | Prostatic Neoplasms, Castration-Resistant | 5.6% |
| 385 | Polycystic Ovary Syndrome | 5.5% |
| 386 | Glioblastoma | 5.4% |
| 387 | Neuroblastoma | 5.4% |
| 388 | Glioblastoma Multiforme | 5.4% |
| 389 | Nasopharyngeal carcinoma | 5.4% |
| 390 | Cystadenocarcinoma | 5.3% |
| 391 | Fibrosarcoma | 5.3% |
| 392 | Osteosarcoma | 5.3% |
| 393 | Mucoepidermoid Carcinoma | 5.3% |
| 394 | Choroid Plexus Papilloma | 5.3% |
| 395 | Dwarfism | 5.3% |
| 396 | Ganglioneuroblastoma | 5.2% |
| 397 | Fascioliasis | 5.2% |
| 398 | Lymphoma | 5.2% |
| 399 | Echinococcosis, Hepatic | 5.2% |
| 400 | Melena | 5.2% |
| 401 | Massive Hepatic Necrosis | 5.1% |
| 402 | Esophageal Achalasia | 5.1% |
| 403 | Anal Fissure | 5.1% |
| 404 | Intestinal Pseudo-Obstruction | 5.1% |
| 405 | Irritable Bowel Syndrome | 5.1% |
| 406 | Superior Mesenteric Artery Syndrome | 5.1% |
| 407 | Emphysematous Cholecystitis | 5.1% |
| 408 | Neurogenic Bowel | 5.1% |
| 409 | Sphincter of Oddi Dysfunction | 5.1% |
| 410 | Chemical and Drug Induced Liver Injury, Chronic | 5.1% |
| 411 | Anal Ulcer | 5.1% |
| 412 | Reye Syndrome | 5.1% |
| 413 | Hematemesis | 5.1% |
| 414 | Adenofibroma | 5.1% |
| 415 | Fibroadenoma | 5.1% |
| 416 | Malignant Fibrous Histiocytoma | 5.1% |
| 417 | Tonsillar Neoplasms | 5% |
| 418 | Cerebellar Neoplasms | 5% |
| 419 | Hemorrhoids | 4.9% |
| 420 | Autoimmune hepatitis | 4.9% |
| 421 | Afferent Loop Syndrome | 4.9% |
| 422 | Celiac Disease | 4.9% |
| 423 | Short Bowel Syndrome | 4.9% |
| 424 | Sprue, Tropical | 4.9% |
| 425 | Steatorrhea | 4.9% |
| 426 | Rectocele | 4.9% |
| 427 | Sprue | 4.9% |
| 428 | Diverticulitis | 4.9% |
| 429 | Dumping Syndrome | 4.9% |
| 430 | Rectal Prolapse | 4.9% |
| 431 | Bowen's Disease | 4.8% |
| 432 | Paraganglioma | 4.8% |
| 433 | Rhabdomyosarcoma | 4.8% |
| 434 | Giant Cell Tumor of Bone | 4.8% |
| 435 | Endometrial Stromal Sarcoma | 4.8% |
| 436 | Neurofibrosarcoma | 4.8% |
| 437 | Congenital Hypothyroidism | 4.8% |
| 438 | Carcinoid Heart Disease | 4.8% |
| 439 | Adrenal Cortex Diseases | 4.7% |
| 440 | Euthyroid Sick Syndromes | 4.7% |
| 441 | Goiter | 4.7% |
| 442 | Hyperparathyroidism | 4.7% |
| 443 | Hyperthyroidism | 4.7% |
| 444 | Hyperthyroxinemia | 4.7% |
| 445 | Hypogonadism | 4.7% |
| 446 | Hypoparathyroidism | 4.7% |
| 447 | Hypothyroidism | 4.7% |
| 448 | Delayed Puberty | 4.7% |
| 449 | Precocious Puberty | 4.7% |
| 450 | Thyroiditis | 4.7% |
| 451 | Hypogonadotropic hypogonadism | 4.7% |
| 452 | Testotoxicosis | 4.7% |
| 453 | Secondary hypothyroidism | 4.7% |
| 454 | Primary Hyperthyroidism | 4.7% |
| 455 | Primary Hypothyroidism | 4.7% |
| 456 | Hydatidiform Mole | 4.6% |
| 457 | Nasopharyngeal Neoplasms | 4.6% |
| 458 | Adenoma | 4.6% |
| 459 | Ameloblastoma | 4.6% |
| 460 | Angiokeratoma | 4.6% |
| 461 | Carcinoma | 4.6% |
| 462 | Chordoma | 4.6% |
| 463 | Hemangioma | 4.6% |
| 464 | hemangiopericytoma | 4.6% |
| 465 | Lymphangioma | 4.6% |
| 466 | Mesenchymoma | 4.6% |
| 467 | Nevus | 4.6% |
| 468 | Teratoma | 4.6% |
| 469 | Hepatoblastoma | 4.6% |
| 470 | Mixed Tumor, Mullerian | 4.6% |
| 471 | Germinoma | 4.6% |
| 472 | Teratocarcinoma | 4.6% |
| 473 | Angiofibroma | 4.6% |
| 474 | Sarcoma | 4.6% |
| 475 | Epithelioma | 4.6% |
| 476 | Dermatofibrosarcoma | 4.6% |
| 477 | Dermatofibrosarcoma Protuberans | 4.6% |
| 478 | Graves Disease | 4.6% |
| 479 | Variegate Porphyria | 4.5% |
| 480 | Acute intermittent porphyria | 4.5% |
| 481 | Porphyria Cutanea Tarda | 4.5% |
| 482 | Lymphangioleiomyomatosis | 4.5% |
| 483 | Hepatitis, Viral, Animal | 4.4% |
| 484 | Pruritus Ani | 4.4% |
| 485 | Pheochromocytoma | 4.3% |
| 486 | Alveolar rhabdomyosarcoma | 4.3% |
| 487 | Giardiasis | 4.3% |
| 488 | Hepatitis E | 4.3% |
| 489 | Hepatitis B | 4.3% |
| 490 | Hepatitis C | 4.3% |
| 491 | Diverticulum | 4.3% |
| 492 | Hepatitis A | 4.3% |
| 493 | Diverticulosis | 4.3% |
| 494 | Hepatic Encephalopathy | 4.2% |
| 495 | Paranasal Sinus Neoplasms | 4.2% |
| 496 | Laryngopharyngeal Reflux | 4.2% |
| 497 | Testicular Diseases | 4% |
| 498 | Ovarian Diseases | 3.9% |
| 499 | Empty Sella Syndrome | 3.9% |
| 500 | Hyperpituitarism | 3.9% |
| 501 | Hypopituitarism | 3.9% |
| 502 | Hypophysitis | 3.9% |
| 503 | Plasmacytoma | 3.9% |
| 504 | Malignant histiocytosis | 3.9% |
| 505 | Lymphatic Metastasis | 3.9% |
| 506 | Neoplasms, Unknown Primary | 3.9% |
| 507 | Leukemic Infiltration | 3.9% |
| 508 | Histiocytic sarcoma | 3.9% |
| 509 | Neoplasm Micrometastasis | 3.9% |
| 510 | Lactose Intolerance | 3.7% |
| 511 | Diabetic Foot | 3.7% |
| 512 | Maxillary Sinus Neoplasms | 3.7% |
| 513 | Zellweger Syndrome | 3.6% |
| 514 | Gestational Diabetes | 3.5% |
| 515 | Latent Autoimmune Diabetes in Adults | 3.5% |
| 516 | Cushing Syndrome | 3.4% |
| 517 | Hyperaldosteronism | 3.4% |
| 518 | Hyperparathyroidism, Secondary | 3.4% |
| 519 | Hypoaldosteronism | 3.4% |
| 520 | Thyrotoxicosis | 3.4% |
| 521 | Hyperparathyroidism, Primary | 3.4% |
| 522 | Thyroid Hormone Resistance Syndrome | 3.4% |
| 523 | Diabetes Insipidus | 3.4% |
| 524 | Diabetes Mellitus, Experimental | 3.4% |
| 525 | Adenocarcinoma | 3.4% |
| 526 | Carcinoma in Situ | 3.4% |
| 527 | Carcinoma, Transitional Cell | 3.4% |
| 528 | Phyllodes Tumor | 3.4% |
| 529 | Dysgerminoma | 3.4% |
| 530 | Hemangioendothelioma | 3.4% |
| 531 | Lipoma | 3.4% |
| 532 | Myoma | 3.4% |
| 533 | Myxoma | 3.4% |
| 534 | Neuroma | 3.4% |
| 535 | Papilloma | 3.4% |
| 536 | Pseudomyxoma Peritonei | 3.4% |
| 537 | Seminoma | 3.4% |
| 538 | Papillomatosis | 3.4% |
| 539 | Angiolipoma | 3.4% |
| 540 | Myelolipoma | 3.4% |
| 541 | Neoplasms, Bone Tissue | 3.4% |
| 542 | Neoplasms, Fibrous Tissue | 3.4% |
| 543 | Smooth Muscle Tumor | 3.4% |
| 544 | Adenomatosis, Pulmonary | 3.4% |
| 545 | Adenomatous Polyps | 3.4% |
| 546 | Carcinoma, Large Cell | 3.4% |
| 547 | Carcinoma, Small Cell | 3.4% |
| 548 | Desmoplastic Small Round Cell Tumor | 3.4% |
| 549 | Chondroma | 3.4% |
| 550 | Enchondroma | 3.4% |
| 551 | Hodgkin Disease | 3.4% |
| 552 | Lymphoma, Non-Hodgkin | 3.4% |
| 553 | Kallmann Syndrome | 3.4% |
| 554 | Hepatolenticular Degeneration | 3.3% |
| 555 | Xeroderma Pigmentosum | 3.1% |
| 556 | Cryptosporidiosis | 3.1% |
| 557 | Hermaphroditism | 3.1% |
| 558 | Disorders of Sex Development | 3.1% |
| 559 | Klinefelter Syndrome | 3% |
| 560 | Primary amyloidosis | 3% |
| 561 | Pituitary Apoplexy | 3% |
| 562 | Addison Disease | 3% |
| 563 | Diabetic Angiopathies | 3% |
| 564 | Autoimmune thyroiditis | 3% |
| 565 | Primary Adrenal Insufficiency | 3% |
| 566 | Diabetic Neuropathies | 2.9% |
| 567 | Myxedema | 2.9% |
| 568 | Orchitis | 2.9% |
| 569 | Diabetic Amyotrophy | 2.9% |
| 570 | Diabetic Autonomic Neuropathy | 2.9% |
| 571 | Diabetic Cardiomyopathies | 2.9% |
| 572 | Ovarian Hyperstimulation Syndrome | 2.9% |
| 573 | Hyperprolactinemia | 2.9% |
| 574 | Leukemia, Myelomonocytic, Chronic | 2.9% |
| 575 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.9% |
| 576 | Hyperglycemic Hyperosmolar Nonketotic Coma | 2.9% |
| 577 | Hashimoto Disease | 2.9% |
| 578 | Adenoid Cystic Carcinoma | 2.8% |
| 579 | fibroma | 2.8% |
| 580 | Fibromatosis | 2.8% |
| 581 | Osteoblastoma | 2.8% |
| 582 | Osteoma | 2.8% |
| 583 | Rhabdomyoma | 2.8% |
| 584 | Chondromatosis | 2.8% |
| 585 | Adenocarcinoma, Clear Cell | 2.8% |
| 586 | Cholangiocarcinoma | 2.8% |
| 587 | Cervical Intraepithelial Neoplasia | 2.8% |
| 588 | Hemangioblastoma | 2.8% |
| 589 | Lymphoma, Extranodal NK-T-Cell | 2.8% |
| 590 | Rift Valley Fever | 2.8% |
| 591 | CREST Syndrome | 2.7% |
| 592 | Mastocytosis | 2.6% |
| 593 | Sturge-Weber Syndrome | 2.6% |
| 594 | Gigantism | 2.6% |
| 595 | Fibromatosis, Aggressive | 2.6% |
| 596 | Fibromatosis, Abdominal | 2.6% |
| 597 | Klatskin Tumor | 2.6% |
| 598 | Cell Transformation, Viral | 2.6% |
| 599 | Diabetic Nephropathy | 2.6% |
| 600 | Acromegaly | 2.5% |
| 601 | Hemangioma, Cavernous | 2.5% |
| 602 | Hyperandrogenism | 2.5% |
| 603 | Anovulation | 2.5% |
| 604 | Diabetic Ketoacidosis | 2.5% |
| 605 | Leukemia, T-Cell | 2.5% |
| 606 | Oophoritis | 2.5% |
| 607 | Leukemia, B-Cell | 2.5% |
| 608 | neurofibroma | 2.5% |
| 609 | Lymphoma, Follicular | 2.5% |
| 610 | T-Cell Lymphoma | 2.5% |
| 611 | Mantle cell lymphoma | 2.5% |
| 612 | Waldenstrom Macroglobulinemia | 2.5% |
| 613 | Multiple Myeloma | 2.5% |
| 614 | Mastocytoma | 2.4% |
| 615 | Mastocytosis, Systemic | 2.4% |
| 616 | Leukemia, Myeloid, Chronic-Phase | 2.4% |
| 617 | Cryptorchidism | 2.3% |
| 618 | Gonadal Dysgenesis | 2.3% |
| 619 | Adrenogenital Syndrome | 2.3% |
| 620 | Ovotesticular Disorders of Sex Development | 2.3% |
| 621 | Diabetic Retinopathy | 2.1% |
| 622 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.1% |
| 623 | Leukemia, Large Granular Lymphocytic | 2.1% |
| 624 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.1% |
| 625 | Lymphoma, T-Cell, Cutaneous | 2.1% |
| 626 | Lymphoma, AIDS-Related | 2.1% |
| 627 | Enteropathy-Associated T-Cell Lymphoma | 2.1% |
| 628 | Primary Effusion Lymphoma | 2.1% |
| 629 | Dupuytren Contracture | 1.9% |
| 630 | Urticaria Pigmentosa | 1.9% |
| 631 | Mycosis Fungoides | 1.9% |
| 632 | Lymphomatoid Papulosis | 1.9% |
| 633 | Plasmablastic lymphoma | 1.9% |
| 634 | Turner Syndrome | 1.8% |
| 635 | Burkitt Lymphoma | 1.7% |
| 636 | Sezary Syndrome | 1.5% |
| 637 | Radicular Cyst | 1.5% |
| 638 | Waterhouse-Friderichsen Syndrome | 1.4% |
| 639 | Renal Osteodystrophy | 1.4% |
| 640 | Renal rickets | 1.4% |
| 641 | Adrenoleukodystrophy | 0.9% |
